| Product Code: ETC6965461 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Denmark Oncology Companion Diagnostic Market Overview |
3.1 Denmark Country Macro Economic Indicators |
3.2 Denmark Oncology Companion Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Denmark Oncology Companion Diagnostic Market - Industry Life Cycle |
3.4 Denmark Oncology Companion Diagnostic Market - Porter's Five Forces |
3.5 Denmark Oncology Companion Diagnostic Market Revenues & Volume Share, By Product & Service, 2021 & 2031F |
3.6 Denmark Oncology Companion Diagnostic Market Revenues & Volume Share, By Technology(Revenue, USD Million, 2021-2031), 2021 & 2031F |
3.7 Denmark Oncology Companion Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Denmark Oncology Companion Diagnostic Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Denmark Oncology Companion Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer in Denmark |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Advancements in oncology research and diagnostics |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for companion diagnostics |
4.3.2 Limited reimbursement for companion diagnostic tests |
4.3.3 High cost associated with companion diagnostic development and implementation |
5 Denmark Oncology Companion Diagnostic Market Trends |
6 Denmark Oncology Companion Diagnostic Market, By Types |
6.1 Denmark Oncology Companion Diagnostic Market, By Product & Service |
6.1.1 Overview and Analysis |
6.1.2 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By Product & Service, 2021- 2031F |
6.1.3 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By Product, 2021- 2031F |
6.1.4 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By Service, 2021- 2031F |
6.2 Denmark Oncology Companion Diagnostic Market, By Technology(Revenue, USD Million, 2021-2031) |
6.2.1 Overview and Analysis |
6.2.2 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By Polymerase chain reaction (PCR), 2021- 2031F |
6.2.3 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By Next-generation sequencing (NGS), 2021- 2031F |
6.2.4 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By Immunohistochemistry (IHC), 2021- 2031F |
6.2.5 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH), 2021- 2031F |
6.2.6 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By Other technologies, 2021- 2031F |
6.3 Denmark Oncology Companion Diagnostic Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.3.3 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By Non-small cell lung cancer, 2021- 2031F |
6.3.4 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By Colorectal cancer, 2021- 2031F |
6.3.5 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By Leukemia, 2021- 2031F |
6.3.6 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By Melanoma, 2021- 2031F |
6.3.7 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By Prostate cancer, 2021- 2031F |
6.4 Denmark Oncology Companion Diagnostic Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.3 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By Pathology/Diagnostic laboratory, 2021- 2031F |
6.4.4 Denmark Oncology Companion Diagnostic Market Revenues & Volume, By Academic medical center, 2021- 2031F |
7 Denmark Oncology Companion Diagnostic Market Import-Export Trade Statistics |
7.1 Denmark Oncology Companion Diagnostic Market Export to Major Countries |
7.2 Denmark Oncology Companion Diagnostic Market Imports from Major Countries |
8 Denmark Oncology Companion Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostics in oncology treatments |
8.2 Number of partnerships and collaborations for companion diagnostic development |
8.3 Rate of integration of companion diagnostics into clinical practice |
9 Denmark Oncology Companion Diagnostic Market - Opportunity Assessment |
9.1 Denmark Oncology Companion Diagnostic Market Opportunity Assessment, By Product & Service, 2021 & 2031F |
9.2 Denmark Oncology Companion Diagnostic Market Opportunity Assessment, By Technology(Revenue, USD Million, 2021-2031), 2021 & 2031F |
9.3 Denmark Oncology Companion Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 Denmark Oncology Companion Diagnostic Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Denmark Oncology Companion Diagnostic Market - Competitive Landscape |
10.1 Denmark Oncology Companion Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Denmark Oncology Companion Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here